𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibody therapy in renal cell carcinoma

✍ Scribed by Egbert Oosterwijk; Otto C. Boerman; Wim J. C. Oyen; Lloyd J. Old; Peter F. A. Mulders


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
235 KB
Volume
26
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sequential therapy in renal cell carcino
✍ Bernard Escudier; Marine Gross Goupil; Christophe Massard; Karim Fizazi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views
Targeted therapy in renal cell carcinoma
✍ Jean-Jacques Patard; Damien Pouessel; Karim Bensalah; StΓ©phane Culine πŸ“‚ Article πŸ“… 2008 πŸ› Springer-Verlag 🌐 English βš– 225 KB
Radiolabeled monoclonal antibody G250 in
✍ E. Oosterwijk; F. M. J. Debruyne πŸ“‚ Article πŸ“… 1995 πŸ› Springer-Verlag 🌐 English βš– 691 KB

The current status of iodine 131-radiolabeled monoclonal antibody G250 (mAb G250) in renal-cell carcinoma (RCC) is described. This mAb recognizes a tumor-associated antigen that is expressed on the cell surface of almost all RCC but is not expressed on normal tissues, with the exception of gastric m

Renal cell carcinoma: physiology, diagno
✍ A. S. Abi-Aad; A. Belldegrun; J. B. deKernion πŸ“‚ Article πŸ“… 1991 πŸ› Springer-Verlag 🌐 English βš– 539 KB

Renal call carcinoma (RCC) is the most common malignancy of the kidney in adults. Heredity appears to play a role within the etiology of RCC. Recent evidence indicates that deletions and translocations involving the short arm of chromosome 3 are important for the oncogenesis and tumor progression of